Intratumoral heterogeneity of HER-2 gene amplification and protein overexpression in breast cancer
- 1 June 2010
- journal article
- case report
- Published by Elsevier in Human Pathology
- Vol. 41 (6) , 914-917
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Genotypic Intratumoral Heterogeneity in Breast Carcinoma With HER2/neu AmplificationAmerican Journal of Clinical Pathology, 2009
- Genetic heterogeneity in HER2 testing in breast cancer: panel summary and guidelines.Archives of Pathology & Laboratory Medicine, 2009
- Clinical importance of HER2 immunohistologic heterogeneous expression in core-needle biopsies vs resection specimens for equivocal (immunohistochemical score 2+) casesLaboratory Investigation, 2008
- Heterogeneity of Breast Cancer Metastases: Comparison of Therapeutic Target Expression and Promoter Methylation Between Primary Tumors and Their Multifocal MetastasesClinical Cancer Research, 2008
- Intratumoral heterogeneity of HER2/neu expression and its consequences for the management of advanced breast cancerAnnals of Oncology, 2008
- HER2gene status in primary breast cancers and matched distant metastasesBreast Cancer Research, 2007
- Analysis of Intratumoral Heterogeneity and Amplification Status in Breast Carcinomas With Equivocal (2+) HER-2 ImmunostainingAmerican Journal of Clinical Pathology, 2005
- Analysis of Intratumoral Heterogeneity and Amplification Status in Breast Carcinomas With Equivocal (2+) HER-2 ImmunostainingAmerican Journal of Clinical Pathology, 2005
- Change of HER‐2/neu status in a subset of distant metastases from breast carcinomasThe Journal of Pathology, 2004
- Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sitesAnnals of Oncology, 2002